MétaCan
Menu
← Back to cohort
Record W4417017570 · doi:10.1182/blood-2025-7684

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

2025· article· en· W4417017570 on OpenAlexaff
Moazzam Shahzad, Aqeeb Ur Rehman, Shah Rukh, Muhammad Kashif Amin, Amir Kasaeian, Hammad Shafi, Forat Lutfi, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Bibliographic record

VenueBlood · 2025
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsPancreas Centre (Canada)
Fundersnot available
KeywordsHazard ratioHematopoietic stem cell transplantationProportional hazards modelTransplantationGraft-versus-host diseaseConfidence intervalRetrospective cohort studyComorbidityCyclophosphamide

Abstract

fetched live from OpenAlex

Abstract Background Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for several hematologic disorders. While disease- and transplant-related factors significantly impact post-transplant outcomes, sociodemographic and patient-related determinants may also play a crucial role in the success of allo-HCT. We aimed to investigate the influence of sociodemographic and patient-related determinants on outcomes after unmatched allo-HCT using post-transplant cyclophosphamide (PT-Cy)-based graft-versus-host disease (GVHD) prophylaxis. Methods A retrospective multicenter analysis was conducted using the publicly available Center for International Blood and Marrow Transplant (CIBMTR) registry from 2017 to 2021 using P-5891 data by Shaffer et al. We evaluated the impact of recipient age, gender, race and ethnicity, graft source, disease type, disease risk index, donor age, donor-recipient CMV status, karnofsky performance status (KPS), and Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) on overall survival (OS), relapse, non-relapse mortality (NRM), grade II-IV acute GVHD (aGVHD), grade III-IV aGVHD, moderate/severe chronic GVHD (cGVHD), and GVHD-free relapse-free survival (GRFS). Patient-, disease- and transplant-related factors were compared between groups using the Chi-square test for categorical variables and the Wilcoxon two-sample test for continuous variables. Cox proportional hazards regression analyses were performed to assess outcomes. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated. Variables with p < 0.1 in univariable analysis and clinically relevant variables were included in the multivariable models. Statistical analyses were conducted using Stata version 18, and significance was defined at p < 0.05. Results We included a total of 2,271 unrelated allo-HCT recipients receiving PT-Cy-based GVHD prophylaxis. Mean age was 57.0 (SD 13.9) years, and 56.1% were male. The graft source was bone marrow in 90% of patients and peripheral blood in 10%. The primary hematologic malignancies included acute myeloid leukemia (AML) (54%), myelodysplastic syndrome (MDS) (29.5%), and acute lymphoblastic leukemia (ALL) (16.5%). The race of patients was Caucasian (87%), African American (4.8%), Asian, and others (9%). The conditioning regimen was myeloablative in 39.8% of patients. The KPS was <90 in 44.8% of patients. The HCT-CI was ≥3 in 53% patients. The median OS was 24 (IQR 11.6-36) months. Grade II-IV aGVHD, grade III-IV aGVHD, moderate/severe cGVHD, relapse, and mortality rates were 29.1%, 6.4%, 11.4%, 27.1%, and 36.9%, respectively. After adjusting for significant variables in multivariate regression analysis, recipient age (HR = 1.010, 95% CI 1.004-1.017; p = 0.003), <90 KPS at transplant (HR = 1.20, 95% CI 1.04-1.38; p = 0.013), and higher HCT-CI (HR = 1.11, 95% CI 1.08-1.15; p < 0.001) predicted inferior OS. Lower risk of relapse was observed in patients with ALL (HR = 0.71, 95% CI 0.54-0.93; p = 0.014). However, risk of relapse was higher among patients receiving non-myeloablative conditioning (HR = 1.43, 95% CI 1.12-1.82; p = 0.004). In addition, recipient age (HR = 1.03, 95% CI 1.02-1.04; p < 0.001), <90 KPS (HR = 1.27, 95% CI 1.03-1.56; p = 0.025), ALL (HR = 1.58, 95% CI 1.17-2.14; p = 0.003), and higher HCT-CI (HR = 1.15, 95% CI 1.10-1.20; p < 0.001) predicted worse NRM. For GRFS, higher risk was observed with Black race (HR = 1.38, 95% CI 1.06-1.78; p = 0.016), higher HCT-CI (HR = 1.08, 95% CI 1.04-1.10; p < 0.001), donor age (HR = 1.008, 95% CI 1.000-1.015; p = 0.042), and reduced intensity conditioning (HR = 1.18, 95% CI 1.01-1.37; p = 0.034). Moreover, higher HCT-CI also predicted a higher risk of aGVHD III-IV (HR = 1.12, 95% CI 1.04-1.20; p = 0.003). High and very high-risk disease status at the time of transplant predicted worse OS, relapse rate, and GRFS. Conclusion In this multicenter analysis, we found that recipient age, performance, and comorbidity status, disease type, disease risk, and conditioning intensity consistently predict worse outcomes in patients undergoing unmatched allo-HCT with PT-Cy prophylaxis. Donor age and race may also impact outcomes; however, further investigation is warranted. Sex, graft source, donor-recipient CMV status, and ethnicity do not appear to influence outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.241
Teacher spread0.233 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBlood→Same topicHematopoietic Stem Cell Transplantation→French-language works237,207→